Approach opens a new avenue to study the biology of acute leukemia and for the development of new drugs.
5:00 AM
Author |
![protein in pink and blue an light grey with lab note badge spelled out on bottom right in yellow background and navy font](/sites/default/files/styles/article_main_image/public/blog/Protein-Leukemia-3D-Model-Pink.jpg?h=bfaa3d24&itok=DGBvIs_R)
The protein made by the ASH1L gene plays a key role in the development of acute leukemia, along with other diseases. The ASH1L protein, however, has been challenging to target therapeutically.
Now a team of researchers led by Jolanta Grembecka, Ph.D., and Tomasz Cierpicki, Ph.D., from the University of Michigan has developed first-in-class small molecules to inhibit ASH1L's SET domain — preventing critical molecular interactions in the development and progression of leukemia.
The team's findings, which used fragment-based screening, followed by medicinal chemistry and a structure-based design, appear in Nature Communications.
In mouse models of mixed lineage leukemia, the lead compound, known as AS-99, successfully reduced leukemia progression.
"This work points to a new, exiting avenue to develop new therapeutic agents against acute leukemia, as well as providing a new approach to further study the biological functions of ASH1L and its role in the development of the disease," says Grembecka, associate professor of pathology at Michigan Medicine and co-director of the developmental therapeutics program at the U-M Rogel Cancer Center.
The study was a close collaboration between her lab and the lab of co-senior author Cierpicki, an associate professor of biophysics and pathology.
Paper citied: "Discovery of first-in-class inhibitors of ASH1L histone methyltransferase with anti-leukemic activity," Nature Communications. DOI:10.1038/s41467-021-23152-6
![Health Lab word mark overlaying blue cells](/sites/default/files/styles/article_sidebar/public/2022-12/health_lab_article_tag.jpg?h=d1cb525d&itok=fHtGF34e)
Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.
![](/sites/default/files/2022-10/u-hospital-spring_large_1130x635.jpg)
Department of Communication at Michigan Medicine
Want top health & research news weekly? Sign up for Health Lab’s newsletters today!
![lime green structure with purple in left middle and lab note badge in navy and yellow in bottom right](https://www.michiganmedicine.org/sites/default/files/styles/card/public/blog/Green-Blob-Spirals-Blue-Molecule.jpg?h=bfaa3d24&itok=UNj-nPJv)
![blue purple cell dots on white background all over in different patterns](https://www.michiganmedicine.org/sites/default/files/styles/card/public/2024-07/hexagons-pattern-geometric-shapes-grid.jpg?h=f0fb51a5&itok=hZtmLqYA)
![iv chemo bags](https://www.michiganmedicine.org/sites/default/files/styles/card/public/2024-07/chemotherapy-drugs-iv-bag-pole.jpg?h=f0fb51a5&itok=BTEQSIVp)
![close up photo of yellow pills lined up on a bright blue matt](https://www.michiganmedicine.org/sites/default/files/styles/card/public/2024-07/yellow-pills-rows-blue-background_0.jpg?h=f0fb51a5&itok=q-coTU_Z)
![two women, one older one younger, looking concerned listening to a provider across from them with back to camera](https://www.michiganmedicine.org/sites/default/files/styles/card/public/2024-07/older-woman-younger-woman-talk-with-counselor.jpg?h=f0fb51a5&itok=EO9CsfyP)
![rat in blue with yellow bright brain with blue abstract background](https://www.michiganmedicine.org/sites/default/files/styles/card/public/2024-07/rat_blue_bright_brain_yellow.jpg?h=ade979fe&itok=QAUYwnTy)